Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    October 2017
  1. YU CF, Chen FH, Lu MH, Hong JH, et al
    Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion.
    Br J Cancer. 2017 Oct 24. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    September 2017
  2. TAY RY, Blackley E, McLean C, Moore M, et al
    Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.
    Br J Cancer. 2017;117:921-924.
    PubMed     Text format     Abstract available


  3. BENKE G, Turner MC, Fleming S, Figuerola J, et al
    Occupational solvent exposure and risk of glioma in the INTEROCC study.
    Br J Cancer. 2017 Sep 14. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  4. KLIMOV S, Rida PC, Aleskandarany MA, Green AR, et al
    Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers.
    Br J Cancer. 2017;117:826-834.
    PubMed     Text format     Abstract available


    August 2017
  5. ITO S, Koso H, Sakamoto K, Watanabe S, et al
    RNA helicase DHX15 acts as a tumour suppressor in glioma.
    Br J Cancer. 2017 Aug 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  6. ABDUL RAHIM SA, Dirkse A, Oudin A, Schuster A, et al
    Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.
    Br J Cancer. 2017 Aug 10. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  7. SHI C, Ren L, Sun C, Yu L, et al
    miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
    Br J Cancer. 2017 Aug 8. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  8. ADLER NR, Wolfe R, Kelly JW, Haydon A, et al
    Tumour mutation status and sites of metastasis in patients with cutaneous melanoma.
    Br J Cancer. 2017 Aug 8. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    June 2017
  9. MACIACZYK D, Picard D, Zhao L, Koch K, et al
    CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Br J Cancer. 2017 Jun 1. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    May 2017
  10. PARAKH S, Park JJ, Mendis S, Rai R, et al
    Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.
    Br J Cancer. 2017;116.
    PubMed     Text format     Abstract available


  11. DONG Z, Lei Q, Yang R, Zhu S, et al
    Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
    Br J Cancer. 2017 May 11. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    March 2017
  12. HAN S, Meng L, Jiang Y, Cheng W, et al
    Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.
    Br J Cancer. 2017 Mar 30. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  13. JOHANSEN C, Schuz J, Andreasen AS, Dalton SO, et al
    Study designs may influence results: the problems with questionnaire-based case-control studies on the epidemiology of glioma.
    Br J Cancer. 2017 Mar 7. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  14. KINSLER VA, O'Hare P, Jacques T, Hargrave D, et al
    MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children.
    Br J Cancer. 2017 Mar 2. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    January 2017
  15. ANDERSEN KK, Duun-Henriksen AK, Frederiksen MH, Winther JF, et al
    Ninth grade school performance in Danish childhood cancer survivors.
    Br J Cancer. 2017;116:398-404.
    PubMed     Text format     Abstract available


    November 2016
  16. LLAGUNO SR, Parada LF
    Cell of origin of glioma: biological and clinical implications.
    Br J Cancer. 2016 Nov 10. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    October 2016
  17. WILLIAMS M, Treasure P, Greenberg D, Brodbelt A, et al
    Surgeon volume and 30 day mortality for brain tumours in England.
    Br J Cancer. 2016 Oct 20. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


  18. GUPTA A, Roberts C, Tysoe F, Goff M, et al
    RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.
    Br J Cancer. 2016 Oct 6. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    June 2016
  19. BERNARDO BM, Orellana RC, Weisband YL, Hammar N, et al
    Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality.
    Br J Cancer. 2016 Jun 2. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    May 2016
  20. DESOUZA RM, Shaweis H, Han C, Sivasubramaniam V, et al
    Has the survival of patients with glioblastoma changed over the years?
    Br J Cancer. 2016 May 26. doi: 10.1038/bjc.2016.
    PubMed     Text format    


    April 2016
  21. POTTEGARD A, Garcia Rodriguez LA, Rasmussen L, Damkier P, et al
    Use of tricyclic antidepressants and risk of glioma: a nationwide case-control study.
    Br J Cancer. 2016 Apr 26. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


  22. ZAKARIA R, Platt-Higgins A, Rathi N, Crooks D, et al
    Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.
    Br J Cancer. 2016 Apr 21. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    February 2016
  23. THOMSON AH, McGrane J, Mathew J, Palmer J, et al
    Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes.
    Br J Cancer. 2016 Feb 23. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


  24. KOUKOURAKIS MI, Mitrakas AG, Giatromanolaki A
    Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve.
    Br J Cancer. 2016 Feb 18. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


  25. CONWAY GE, Casey A, Milosavljevic V, Liu Y, et al
    Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide.
    Br J Cancer. 2016;114:435-43.
    PubMed     Text format     Abstract available


  26. BERRINGTON DE GONZALEZ A, Salotti JA, McHugh K, Little MP, et al
    Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions.
    Br J Cancer. 2016;114:388-94.
    PubMed     Text format     Abstract available


  27. GUNNES MW, Lie RT, Bjorge T, Ghaderi S, et al
    Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study.
    Br J Cancer. 2016;114:348-56.
    PubMed     Text format     Abstract available


    December 2015
  28. FEILCHENFELDT J, Varga Z, Siano M, Grabsch HI, et al
    Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
    Br J Cancer. 2015;113:1747.
    PubMed     Text format    


  29. DESOUZA RM, Shaweis H, Han C, Sivasubramiam V, et al
    Has the survival of patients with glioblastoma changed over the years?
    Br J Cancer. 2015 Dec 15. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  30. MURRAY MJ, Bell E, Raby KL, Rijlaarsdam MA, et al
    A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Br J Cancer. 2015 Dec 15. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  31. ZAKARIA Z, Tivnan A, Flanagan L, Murray DW, et al
    Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.
    Br J Cancer. 2015 Dec 10. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  32. WONG ET, Lok E, Gautam S, Swanson KD, et al
    Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.
    Br J Cancer. 2015;113:1642.
    PubMed     Text format    


  33. THURING C, Follin E, Geironson L, Freyhult E, et al
    HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.
    Br J Cancer. 2015;113:1640.
    PubMed     Text format    


    October 2015
  34. WILKINS A, Furness A, W Corbett R, Bloomfield A, et al
    The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma.
    Br J Cancer. 2015 Oct 20. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  35. PEDERSEN C, Johansen C, Schuz J, Olsen JH, et al
    Residential exposure to extremely low-frequency magnetic fields and risk of childhood leukaemia, CNS tumour and lymphoma in Denmark.
    Br J Cancer. 2015 Oct 20. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    September 2015
  36. ELLSWORTH S, Grossman SA
    Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.
    Br J Cancer. 2015 Sep 8. doi: 10.1038/bjc.2015.
    PubMed     Text format    


  37. WONG ET, Swanson KD
    Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.
    Br J Cancer. 2015 Sep 8. doi: 10.1038/bjc.2015.
    PubMed     Text format    


    August 2015
  38. FEILCHENFELDT J, Varga Z, Siano M, Grabsch HI, et al
    Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  39. THURING C, Follin E, Geironson L, Freyhult E, et al
    The environment HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  40. MARIS C, D'Haene N, Trepant AL, Le Mercier M, et al
    IGF-IR: a new prognostic biomarker for human glioblastoma.
    Br J Cancer. 2015 Aug 20. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    June 2015
  41. WONG ET, Lok E, Gautam S, Swanson KD, et al
    Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.
    Br J Cancer. 2015 Jun 30. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  42. BEIJE N, Kraan J, Taal W, van der Holt B, et al
    Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB tri
    Br J Cancer. 2015 Jun 4. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    May 2015
  43. CHEN Y, Zhang J, Huang X, Zhang J, et al
    High leukocyte mitochondrial DNA content contributes to poor prognosis in glioma patients through its immunosuppressive effect.
    Br J Cancer. 2015 May 28. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: